Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4,5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity

Currently, the humanity is in a fierce battle against various health-related challenges especially those associated with human malignancies. This created the urge to develop potent and selective inhibitors for tumor cells through targeting specific oncogenic proteins possessing crucial roles in canc...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2022-07, Vol.12 (1), p.12821-12821, Article 12821
Main Authors: Eldehna, Wagdy M., El Hassab, Mahmoud A., Elsayed, Zainab M., Al-Warhi, Tarfah, Elkady, Hazem, Abo-Ashour, Mahmoud F., Abourehab, Mohammed A. S., Eissa, Ibrahim H., Abdel-Aziz, Hatem A.
Format: Article
Language:English
Subjects:
631/154/309
639/638/309
692/4028
Alcohol
Antitumor agents
Apoptosis
Binding sites
Breast cancer
Caustic soda
Cell cycle
Chemistry
Epidermal growth factor receptors
Ethanol
Growth factors
Humanities and Social Sciences
Hybrids
Kinases
Metastasis
Molecular modelling
multidisciplinary
Pharmaceutical sciences
Pharmacy
Pyrazoles
Science
Science (multidisciplinary)
Tumor cells
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Currently, the humanity is in a fierce battle against various health-related challenges especially those associated with human malignancies. This created the urge to develop potent and selective inhibitors for tumor cells through targeting specific oncogenic proteins possessing crucial roles in cancer progression and survive. In this respect, new series of pyrazole-thiazol-4-one hybrids ( 9a–p ) were synthesized as potential anticancer agents. All the synthesized molecules exhibited potent antiproliferative actions against breast cancer (BC) T-47D and MDA-MB-231 cell lines with IC 50 ranges 3.14–4.92 and 0.62–58.01, respectively. Moreover, the most potent anti-proliferative counterparts 9g and 9k were assessed against EGFR. They displayed nanomolar inhibitory activity, IC 50 267 ± 12 and 395 ± 17 nM, respectively. Worth noting, both compounds 9g and 9k induced apoptosis in MDA-MB-231 cells, and resulted in a cell cycle arrest at G2/M phase. Furthermore, an in silico analysis including docking and molecular dynamic simulations was performed.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-022-15050-8